Samus Therapeutics, Inc. logo

Samus Therapeutics, Inc.

Samus Therapeutics is a privately held Boston-based biopharmaceutical company. Samus is developing novel therapeutics targeting the epichaperome, a foundational protein complex emergent from multiple disease states, including cancer and neurological disorders such as Alzheimer’s, Parkinson’s and chronic traumatic encephalopathy.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://www.samustherapeutics.com
Disease Focus
Development Stage
STOCK CODENon Listed
Address
10 South Main Street, MA 01983
Topsfield
United States
Email
Contact Number

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://in.linkedin.com/company/samus-therapeutics-inc.” connections=”true” suffix=””]